These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28798074)

  • 21. Endothelial dysfunction and arterial stiffness in pre-eclampsia demonstrated by the EndoPAT method.
    Meeme A; Buga GA; Mammen M; Namugowa A
    Cardiovasc J Afr; 2017 Jan/Feb 23; 28(1):23-29. PubMed ID: 27196639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Why is placentation abnormal in preeclampsia?
    Fisher SJ
    Am J Obstet Gynecol; 2015 Oct; 213(4 Suppl):S115-22. PubMed ID: 26428489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of maternal characteristics on endothelial-dependent relaxation of myometrial arteries.
    Myers J; Hall C; Wareing M; Gillham J; Baker P
    Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):158-63. PubMed ID: 16139415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiogenesis in the placenta: the role of reactive oxygen species signaling.
    Pereira RD; De Long NE; Wang RC; Yazdi FT; Holloway AC; Raha S
    Biomed Res Int; 2015; 2015():814543. PubMed ID: 25705690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial dysfunction in the pathogenesis of pre-eclampsia in Ghanaian women.
    Adu-Bonsaffoh K; Antwi DA; Gyan B; Obed SA
    BMC Physiol; 2017 Mar; 17(1):5. PubMed ID: 28356151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular dysfunction in preeclampsia.
    Brennan LJ; Morton JS; Davidge ST
    Microcirculation; 2014 Jan; 21(1):4-14. PubMed ID: 23890192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pregnancy hypertension].
    Beaufils M
    Nephrol Ther; 2010 Jun; 6(3):200-14. PubMed ID: 20399167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-eclampsia: contribution of maternal constitutional factors and the consequences for cardiovascular health.
    Barden A
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):826-30. PubMed ID: 16922815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent Insights into the pathogenesis of pre-eclampsia.
    Roberts JM; Lain KY
    Placenta; 2002 May; 23(5):359-72. PubMed ID: 12061851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of regular physical activity in preeclampsia prevention.
    Weissgerber TL; Wolfe LA; Davies GA
    Med Sci Sports Exerc; 2004 Dec; 36(12):2024-31. PubMed ID: 15570135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy.
    Parra-Cordero M; Rodrigo R; Barja P; Bosco C; Rencoret G; Sepúlveda-Martinez A; Quezada S
    Ultrasound Obstet Gynecol; 2013 May; 41(5):538-44. PubMed ID: 22807133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal cardiac autonomic function and fetal heart rate in preeclamptic compared to normotensive pregnancies.
    Swansburg ML; Brown CA; Hains SM; Smith GN; Kisilevsky BS
    Can J Cardiovasc Nurs; 2005; 15(3):42-52. PubMed ID: 16295797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The cardiovascular system in pre-eclampsia. Pathophysiology and sequelae to be treated].
    Schwarz R
    Zentralbl Gynakol; 1991; 113(18):971-80. PubMed ID: 1750296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Physiopathology of preeclampsia].
    Mejía R; Sarto A
    Medicina (B Aires); 1996; 56(3):308-12. PubMed ID: 9035490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial progenitor cells in pregnancy.
    Robb AO; Mills NL; Newby DE; Denison FC
    Reproduction; 2007 Jan; 133(1):1-9. PubMed ID: 17244727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart disease during pregnancy. Which cardiovascular changes are normal or transient?
    Villablanca AC
    Postgrad Med; 1998 Oct; 104(4):183-4, 187-92. PubMed ID: 9793564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maternal plasma levels of endothelial dysfunction mediators including AM, CGRP, sICAM-1 and tHcy in pre-eclampsia.
    Fei X; Hongxiang Z; Qi C; Daozhen C
    Adv Clin Exp Med; 2012; 21(5):573-9. PubMed ID: 23356193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-eclampsia and partial uterine denervation.
    Quinn M
    Med Hypotheses; 2005; 64(3):449-54. PubMed ID: 15617846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation.
    Savvidou MD; Noori M; Anderson JM; Hingorani AD; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Dec; 32(7):871-6. PubMed ID: 18814185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Features of endothelial dysfunction and morphofunctional changes of the uteroplacental complex in experimentally induced pre-eclampsia.
    Tyurenkov IN; Perfilova VN; Smirnov AV; Reznikova LB; Poroyskaya AV; Verovsky VE
    Pregnancy Hypertens; 2016 Oct; 6(4):423-430. PubMed ID: 27939494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.